The answer is no. And understanding why it is no -- deeply, not just as a memorized fact -- is what this lesson is about.

ICH E6(R3) does not prescribe a medium. It prescribes principles. Data must be attributable, legible, contemporaneous, original, accurate, complete, secure, and reliable regardless of whether those data are recorded in blue ink on a multi-part carbon form or typed into a validated electronic system with real-time edit checks and an automated audit trail. The guideline's language in Annex 1, Section 4 is deliberately technology-agnostic: it speaks of "data acquisition tools" and "computerized systems" without privileging one format over another.

But here is what changes, and it changes substantially: the how. How you enter data. How the system prevents certain errors and introduces others. How corrections are made, documented, and verified. How the sponsor accesses the data. How the audit trail is maintained. The principles are the what -- the fixed obligations. The medium determines the how -- the specific workflows that fulfill those obligations.

You will encounter both systems in your career. Some sponsors still use paper CRFs, particularly for small investigator-initiated trials and studies in resource-limited settings. Most large, sponsor-funded trials use EDC. And a surprising number of studies use hybrid workflows -- paper source documents transcribed into electronic CRFs, or EDC systems supplemented with paper worksheets for data that the system cannot capture. You need to understand both.

The answer is no. And understanding why it is no -- deeply, not just as a memorized fact -- is what this lesson is about.

ICH E6(R3) does not prescribe a medium. It prescribes principles. Data must be attributable, legible, contemporaneous, original, accurate, complete, secure, and reliable regardless of whether those data are recorded in blue ink on a multi-part carbon form or typed into a validated electronic system with real-time edit checks and an automated audit trail. The guideline's language in Annex 1, Section 4 is deliberately technology-agnostic: it speaks of "data acquisition tools" and "computerized systems" without privileging one format over another.

But here is what changes, and it changes substantially: the how. How you enter data. How the system prevents certain errors and introduces others. How corrections are made, documented, and verified. How the sponsor accesses the data. How the audit trail is maintained. The principles are the what -- the fixed obligations. The medium determines the how -- the specific workflows that fulfill those obligations.

You will encounter both systems in your career. Some sponsors still use paper CRFs, particularly for small investigator-initiated trials and studies in resource-limited settings. Most large, sponsor-funded trials use EDC. And a surprising number of studies use hybrid workflows -- paper source documents transcribed into electronic CRFs, or EDC systems supplemented with paper worksheets for data that the system cannot capture. You need to understand both.